About the Study

Neuroblastoma: A study of DFMO as maintenance therapy

The purpose of this research study is to evaluate the investigational drug eflornithine HCl (DFMO) for neuroblastoma that is in remission (cured according to medical tests). An investigational drug is one that has not been approved by the U.S. Food and Drug Administration (FDA). This study will look at the ability of this study drug to keep tumors in remission and will also look at the safety and tolerability of DFMO.

Interested in learning more?

Full Study Name: NMTRC014 NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)